Involvement of peripheral mu opioid receptors in scratching behavior in mice

European Journal of Pharmacology

Volumn 649, Issue 1-3, 2010, Pages 336-341

  Yamamoto, Atsuki ^a   Sugimoto, Yukio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

DAMGO; Itch; Loperamide; Naloxone methiodide; Peripheral opioid receptor

Indexed keywords

17 METHYLNALOXONE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; LOPERAMIDE; MU OPIATE RECEPTOR; NALOXONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SCRATCHING; SKIN PRURITUS; SKIN SENSATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE , (TRANS)-ISOMER; ANALGESICS, OPIOID; ANIMALS; ANTIPRURITICS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; INJECTIONS, INTRADERMAL; LOPERAMIDE; MALE; MICE; MICE, INBRED ICR; NALOXONE; OPIOID-RELATED DISORDERS; PRURITUS; QUATERNARY AMMONIUM COMPOUNDS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SKIN;

EID: 78049307526     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.07.039     Document Type: Article

References (32)

1. Ballantyne J.C., Loach A.B., Carr D.B. Itching after epidural and spinal opiates. Pain 1988, 33:149-160.
2. Bigliardi-Qi M., Sumanovski L.T., Büchner S., Rufli T., Bigliardi P.L. Mu-opiate receptor and beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology 2004, 209:183-189.
3. Bigliardi-Qi M., Lipp B., Sumanovski L.T., Buechner S.A., Bigliardi P.L. Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology 2005, 210:91-99.
4. Blunk J.A., Schmelz M., Zeck S., Skov P., Likar R., Koppert W. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth. Analg. 2004, 98:364-370.
5. Cheng B., Liu H.W., Fu X.B., Sheng Z.Y., Li J.F. Coexistence and upregulation of three types of opioid receptors, mu, delta and kappa, in human hypertrophic scars. Br. J. Dermatol. 2008, 158:713-720.
6. Cherny N., Ripamonti C., Pereira J., Davis C., Fallon M., McQuay H., Mercadante S., Pasternak G., Ventafridda V. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J. Clin. Oncol. 2001, 19:2542-2554.
7. DeHaven-Hudkins D.L., Burgos L.C., Cassel J.A., Daubert J.D., DeHaven R.N., Mansson E., Nagasaka H., Yu G., Yaksh T. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity. J. Pharmacol. Exp. Ther. 1999, 289:494-502.
8. DeHaven-Hudkins D.L., Cowan A., Cortes, Burgos L., Daubert J.D., Cassel J.A., DeHaven R.N., Kehner G.B., Kumar V. Antipruritic and antihyperalgesic actions of loperamide and analogs. Life Sci. 2002, 71:2787-2796.
9. Forster A.B., Reeh P.W., Messlinger K., Fischer M.J. High concentrations of morphine sensitize and activate mouse dorsal root ganglia via TRPV1 and TRPA1 receptors. Mol. Pain 2009, 16:5-17.
10. Heykants J., Michiels M., Knaeps A., Brugmans J. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 5: The pharmacokinetics of loperamide in rats and man. Arzneimittelforschung 1974, 24:1649-1653.
11. Kamei J., Nagase H. Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice. Eur. J. Pharmacol. 2001, 418:141-145.
12. Kjellberg F., Tramèr M.R. Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials. Eur. J. Anaesthesiol. 2001, 18:346-357.
13. Ko M.C., Song M.S., Edwards T., Lee H., Naughton N.N. The role of central mu opioid receptors in opioid-induced itch in primates. J. Pharmacol. Exp. Ther. 2004, 310:169-176.
14. Kuraishi Y., Yamaguchi T., Miyamoto T. Itch-scratch responses induced by opioids through central mu opioid receptors in mice. J. Biomed. Sci. 2000, 7:248-252.
15. Lee C.H., Chuang H.Y., Shih C.C., Jong S.B., Chang C.H., Yu H.S. Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis. Br. J. Dermatol. 2006, 154:1100-1107.
16. Levy J.H., Brister N.W., Shearin A., Ziegler J., Hug C.C., Adelson D.M., Walker B.F. Wheal and flare responses to opioids in humans. Anesthesiology 1989, 70:756-760.
17. Lewanowitsch T., Irvine R.J. Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for mu, delta, and kappa opioid receptors in mouse brain homogenates. Brain Res. 2003, 964:302-305.
18. Morita T., Tei Y. Skin reaction to both morphine and fentanyl attenuated by steroids and antihistaminics. J. Pain Symptom Manage. 2006, 32:100-101.
19. Murphy D.B., Sutton J.A., Prescott L.F., Murphy M.B. Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology 1997, 87:765-770.
20. Naono-Nakayama R., Sunakawa N., Ikeda T., Nishimori T. Differential effects of substance P or hemokinin-1 on transient receptor potential channels, TRPV1, TRPA1 and TRPM8, in the rat. Neuropeptides 2010, 44:57-61.
21. Reich A., Szepietowski J.C. Opioid-induced pruritus: an update. Clin. Exp. Dermatol. 2010, 35:2-6.
22. Salemi S., Aeschlimann A., Reisch N., Jüngel A., Gay R.E., Heppner F.L., Michel B.A., Gay S., Sprott H. Detection of kappa and delta opioid receptors in skin-outside the nervous system. Biochem. Biophys. Res. Commun. 2005, 338:1012-1017.
23. Sartain J.B., Barry J.J., Richardson C.A., Branagan H.C. Effect of combining naloxone and morphine for intravenous patient-controlled analgesia. Anesthesiology 2003, 99:148-151.
24. Shim W.S., Oh U. Histamine-induced itch and its relationship with pain. Mol. Pain 2008, 31:4-29.
25. Suzuki T., Izumimoto N., Takezawa Y., Fujimura M., Togashi Y., Nagase H., Tanaka T., Endoh T. Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions. Brain Res. 2004, 995:167-175.
26. Szarvas S., Harmon D., Murphy D. Neuraxial opioid-induced pruritus: a review. J. Clin. Anesth. 2003, 15:234-239.
27. Thomas D.A., Williams G.M., Iwata K., Kenshalo D.R., Dubner R. Effects of central administration of opioids on facial scratching in monkeys. Brain Res. 1992, 10:315-317.
28. Togashi Y., Umeuchi H., Okano K., Ando N., Yoshizawa Y., Honda T., Kawamura K., Endoh T., Utsumi J., Kamei J., Tanaka T., Nagase H. Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur. J. Pharmacol. 2002, 435:259-264.
29. Umeuchi H., Togashi Y., Honda T., Nakao K., Okano K., Tanaka T., Nagase H. Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur. J. Pharmacol. 2003, 477:29-35.
30. Wikström B., Gellert R., Ladefoged S.D., Danda Y., Akai M., Ide K., Ogasawara M., Kawashima Y., Ueno K., Mori A., Ueno Y. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J. Am. Soc. Nephrol. 2005, 16:3742-3747.
31. Yamamoto A., Kuyama S., Kamei C., Sugimoto Y. Characterization of scratching behavior induced by intradermal administration of morphine and fentanyl in mice. Eur. J. Pharmacol. 2010, 627:162-166.
32. Yuan C.S., Foss J.F., O'Connor M., Osinski J., Roizen M.F., Moss J. Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine. Drug Alcohol Depend. 1998, 52:161-165.